Log In
Print
BCIQ
Print
Print this Print this
 

S/GSK1265744

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLong-acting parenteral integrase inhibitor
Molecular Target
Mechanism of ActionHIV integrase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
Partner Shionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today